Erin Wright
Stock Analyst at Morgan Stanley
(4.45)
# 315
Out of 5,118 analysts
246
Total ratings
63.22%
Success rate
14.13%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Maintains: Equal-Weight | $277 → $262 | $258.34 | +1.42% | 5 | Dec 18, 2025 | |
| ELV Elevance Health | Maintains: Equal-Weight | $359 → $352 | $348.38 | +1.04% | 5 | Dec 18, 2025 | |
| ELAN Elanco Animal Health | Maintains: Equal-Weight | $18 → $22 | $22.65 | -2.87% | 12 | Dec 18, 2025 | |
| CVS CVS Health | Maintains: Overweight | $89 → $93 | $80.02 | +16.22% | 7 | Dec 10, 2025 | |
| ZTS Zoetis | Maintains: Overweight | $211 → $175 | $125.98 | +38.91% | 8 | Nov 10, 2025 | |
| MCK McKesson | Maintains: Overweight | $857 → $916 | $830.42 | +10.31% | 10 | Nov 6, 2025 | |
| HSIC Henry Schein | Maintains: Underweight | $55 → $58 | $76.44 | -24.12% | 5 | Nov 5, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Overweight | $765 → $805 | $687.89 | +17.02% | 19 | Nov 4, 2025 | |
| ALGN Align Technology | Maintains: Equal-Weight | $142 → $154 | $157.84 | -2.43% | 25 | Oct 30, 2025 | |
| OPCH Option Care Health | Initiates: Overweight | $35 | $32.19 | +8.73% | 1 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $163 → $204 | $166.54 | +22.49% | 3 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $25 → $32 | $37.84 | -15.43% | 4 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $128 → $140 | $128.59 | +8.87% | 2 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $21.81 | -22.05% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $313 → $330 | $340.25 | -3.01% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $181 → $190 | $207.38 | -8.38% | 12 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $26 | $37.73 | -31.09% | 23 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $379 → $390 | $276.01 | +41.30% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3.5 → $3.2 | $3.39 | -5.60% | 12 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $11.25 | +104.44% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $175.52 | -2.01% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $328.94 | +78.45% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $252.97 | +18.59% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $11.38 | +269.07% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $230.63 | +24.88% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $203.16 | +73.26% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $3.34 | +1,219.34% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $569.97 | -68.24% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $67.34 | -74.75% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $33.26 | +263.80% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $585.07 | -0.87% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $8.85 | +295.48% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $182.36 | +12.42% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $26.62 | -58.68% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $227.11 | -30.87% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $31 → $17 | $2.76 | +515.94% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $488.87 | -37.00% | 1 | Oct 25, 2017 |
Humana
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $277 → $262
Current: $258.34
Upside: +1.42%
Elevance Health
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $359 → $352
Current: $348.38
Upside: +1.04%
Elanco Animal Health
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $18 → $22
Current: $22.65
Upside: -2.87%
CVS Health
Dec 10, 2025
Maintains: Overweight
Price Target: $89 → $93
Current: $80.02
Upside: +16.22%
Zoetis
Nov 10, 2025
Maintains: Overweight
Price Target: $211 → $175
Current: $125.98
Upside: +38.91%
McKesson
Nov 6, 2025
Maintains: Overweight
Price Target: $857 → $916
Current: $830.42
Upside: +10.31%
Henry Schein
Nov 5, 2025
Maintains: Underweight
Price Target: $55 → $58
Current: $76.44
Upside: -24.12%
IDEXX Laboratories
Nov 4, 2025
Maintains: Overweight
Price Target: $765 → $805
Current: $687.89
Upside: +17.02%
Align Technology
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $142 → $154
Current: $157.84
Upside: -2.43%
Option Care Health
Oct 17, 2025
Initiates: Overweight
Price Target: $35
Current: $32.19
Upside: +8.73%
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $163 → $204
Current: $166.54
Upside: +22.49%
Oct 14, 2025
Maintains: Overweight
Price Target: $25 → $32
Current: $37.84
Upside: -15.43%
Oct 3, 2025
Maintains: Equal-Weight
Price Target: $128 → $140
Current: $128.59
Upside: +8.87%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $21.81
Upside: -22.05%
Jul 16, 2025
Maintains: Equal-Weight
Price Target: $313 → $330
Current: $340.25
Upside: -3.01%
Jul 16, 2025
Maintains: Overweight
Price Target: $181 → $190
Current: $207.38
Upside: -8.38%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $37.73
Upside: -31.09%
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $276.01
Upside: +41.30%
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $3.39
Upside: -5.60%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $11.25
Upside: +104.44%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $175.52
Upside: -2.01%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $328.94
Upside: +78.45%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $252.97
Upside: +18.59%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $11.38
Upside: +269.07%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $230.63
Upside: +24.88%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $203.16
Upside: +73.26%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $3.34
Upside: +1,219.34%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $569.97
Upside: -68.24%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $67.34
Upside: -74.75%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $33.26
Upside: +263.80%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $585.07
Upside: -0.87%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $8.85
Upside: +295.48%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $182.36
Upside: +12.42%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $26.62
Upside: -58.68%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $227.11
Upside: -30.87%
Nov 20, 2017
Maintains: Underperform
Price Target: $31 → $17
Current: $2.76
Upside: +515.94%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $488.87
Upside: -37.00%